The Lung Microbiome, Immunity, and the Pathogenesis of Chronic Lung Disease
Open accessThe DOI matches its Crossref record; 131 of the 134 references it cites were found in a registry or an index.
Abstract
The development of culture-independent techniques for microbiological analysis has uncovered the previously unappreciated complexity of the bacterial microbiome at various anatomic sites. The microbiome of the lung has relatively less bacterial biomass when compared with the lower gastrointestinal tract yet displays considerable diversity. The composition of the lung microbiome is determined by elimination, immigration, and relative growth within its communities. Chronic lung disease alters these factors. Many forms of chronic lung disease demonstrate exacerbations that drive disease progression and are poorly understood. Mounting evidence supports ways in which microbiota dysbiosis can influence host defense and immunity, and in turn may contribute to disease exacerbations. Thus, the key to understanding the pathogenesis of chronic lung disease may reside in deciphering the complex interactions between the host, pathogen, and resident microbiota during stable disease and exacerbations. In this brief review we discuss new insights into these labyrinthine relationships.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“For instance, the lungs’ surface approximates 1 m2/kg of body weight and is not sterile (108).”
From The microbiome and human cancer (2021) · cites this paper as [108]
In the citing paper
“metabolites produced by the microbiota could have an important immunoregulatory function specifically targeting the IL-1 axis (590, 591).”
From Aspergillus fumigatus and Aspergillosis in 2019 (2019) · cites this paper as [590]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Diet rapidly and reproducibly alters the human gut microbiome
David, L. A., Maurice, C. F., Carmody, R. N., Gootenberg, D. B., Button, J. E., Wolfe, B. E., Ling, A. V., Devlin, A. S., Varma, Y., Fischbach, M. A., et al. (2014) · Nature · doi:10.1038/nature12820 · Cited by 10,100
Diversity of the Human Intestinal Microbial Flora
Eckburg, P. B., Bik, E. M., Bernstein, C. N., Purdom, E., Dethlefsen, L., Sargent, M., Gill, S. R., Nelson, K. E., & Relman, D. A. (2005) · Science · doi:10.1126/science.1110591 · Cited by 7,913
Human gut microbiome viewed across age and geography
Yatsunenko, T., Rey, F. E., Manary, M. J., Trehan, I., Dominguez-Bello, M. G., Contreras, M., Magris, M., Hidalgo, G., Baldassano, R. N., Anokhin, A. P., et al. (2012) · Nature · doi:10.1038/nature11053 · Cited by 7,815
Enterotypes of the human gut microbiome
MetaHIT Consortium (additional members), Arumugam, M., Raes, J., Pelletier, E., Le Paslier, D., Yamada, T., Mende, D. R., Fernandes, G. R., Tap, J., Bruls, T., et al. (2011) · Nature · doi:10.1038/nature09944 · Cited by 7,548
Dominguez-Bello, M. G., Costello, E. K., Contreras, M., Magris, M., Hidalgo, G., Fierer, N., & Knight, R. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1002601107 · Cited by 4,774
Grice, E. A., & Segre, J. A. (2011) · Nature Reviews Microbiology · doi:10.1038/nrmicro2537 · Cited by 3,143
Gut Microbiota Metabolism of Dietary Fiber Influences Allergic Airway Disease and Hematopoiesis
Trompette, A., Gollwitzer, E. S., Yadava, K., Sichelstiel, A. K., Sprenger, N., Ngom-Bru, C., Blanchard, C., Junt, T., Nicod, L. P., Harris, N. L., et al. (2014) · Nature Medicine · doi:10.1038/nm.3444 · Cited by 2,862
MICROBIAL ECOLOGY OF THE GASTROINTESTINAL TRACT
Savage, D. C. (1977) · Annual Review of Microbiology · doi:10.1146/annurev.mi.31.100177.000543 · Cited by 2,436
Community study of role of viral infections in exacerbations of asthma in 9–11 year old children
Johnston, S. L., Pattemore, P. K., Sanderson, G., Smith, S., Lampe, F., Josephs, L., Symington, P., Toole, S. O., Myint, S. H., Tyrrell, D. A. J., et al. (1995) · BMJ · doi:10.1136/bmj.310.6989.1225 · Cited by 1,991
Raghu, G., Rochwerg, B., Zhang, Y., Garcia, C. A. C., Azuma, A., Behr, J., Brozek, J. L., Collard, H. R., Cunningham, W., Homma, S., et al. (2015) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201506-1063st · Cited by 1,916
Disordered Microbial Communities in Asthmatic Airways
Hilty, M., Burke, C., Pedro, H., Cardenas, P., Bush, A., Bossley, C., Davies, J., Ervine, A., Poulter, L., Pachter, L., et al. (2010) · PLoS ONE · doi:10.1371/journal.pone.0008578 · Cited by 1,824
Exposure to Environmental Microorganisms and Childhood Asthma
Ege, M. J., Mayer, M., Normand, A.-C., Genuneit, J., Cookson, W. O. C. M., Braun-Fahrländer, C., Heederik, D., Piarroux, R., & von Mutius, E. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1007302 · Cited by 1,529
O’Toole, P. W., & Jeffery, I. B. (2015) · Science · doi:10.1126/science.aac8469 · Cited by 1,202
Recognition of peptidoglycan from the microbiota by Nod1 enhances systemic innate immunity
Clarke, T. B., Davis, K. M., Lysenko, E. S., Zhou, A. Y., Yu, Y., & Weiser, J. N. (2010) · Nature Medicine · doi:10.1038/nm.2087 · Cited by 1,154
Acute Exacerbations of Idiopathic Pulmonary Fibrosis
Collard, H. R., Moore, B. B., Flaherty, K. R., Brown, K. K., Kaner, R. J., King, T. E., Lasky, J. A., Loyd, J. E., Noth, I., Olman, M. A., et al. (2007) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200703-463pp · Cited by 1,130
Self-citationRespiratory viruses and exacerbations of asthma in adults
Nicholson, K. G., Kent, J., & Ireland, D. C. (1993) · BMJ · doi:10.1136/bmj.307.6910.982 · Cited by 1,127
Compartmentalized Control of Skin Immunity by Resident Commensals
Naik, S., Bouladoux, N., Wilhelm, C., Molloy, M. J., Salcedo, R., Kastenmuller, W., Deming, C., Quinones, M., Koo, L., Conlan, S., et al. (2012) · Science · doi:10.1126/science.1225152 · Cited by 1,092
Infections and Airway Inflammation in Chronic Obstructive Pulmonary Disease Severe Exacerbations
Papi, A., Bellettato, C. M., Braccioni, F., Romagnoli, M., Casolari, P., Caramori, G., Fabbri, L. M., & Johnston, S. L. (2006) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200506-859oc · Cited by 1,072
Th17 cell induction by adhesion of microbes to intestinal epithelial cells
Atarashi, K., Tanoue, T., Ando, M., Kamada, N., Nagano, Y., Narushima, S., Suda, W., Imaoka, A., Setoyama, H., Nagamori, T., et al. (2015) · Cell · doi:10.1016/j.cell.2015.08.058 · Cited by 1,071 · cited 1×
“The intestine is a known source of Th17 cells through binding of segmented filamentous bacteria to intestinal epithelial cells (125).”
BackgroundSEEMUNGAL, T., HARPER-OWEN, R., BHOWMIK, A., MORIC, I., SANDERSON, G., MESSAGE, S., MacCALLUM, P., MEADE, T. W., JEFFRIES, D. J., JOHNSTON, S. L., et al. (2001) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.164.9.2105011 · Cited by 1,018
Commensal bacteria calibrate the activation threshold of innate antiviral immunity
Abt, M. C., Osborne, L. C., Monticelli, L. A., Doering, T. A., Alenghat, T., Sonnenberg, G. F., Paley, M. A., Antenus, M., Williams, K. L., Erikson, J., et al. (2012) · Immunity · doi:10.1016/j.immuni.2012.04.011 · Cited by 993
Analysis of the lung microbiome in the “healthy” smoker and in COPD.
Erb-Downward, J. R., Thompson, D. L., Han, M. K., Freeman, C. M., McCloskey, L., Schmidt, L. A., Young, V. B., Toews, G. B., Curtis, J. L., Sundaram, B., et al. (2011) · PLoS ONE · doi:10.1371/journal.pone.0016384 · Cited by 973 · cited 1×
“Although individuals exhibit some spatial variation in the microbiota of their respiratory tract, intrasubject variation is significantly less than that of intersubject variation (39).”
BackgroundThe Microbiome and the Respiratory Tract
Dickson, R. P., Erb-Downward, J. R., Martinez, F. J., & Huffnagle, G. B. (2016) · Annual Review of Physiology · doi:10.1146/annurev-physiol-021115-105238 · Cited by 953 · cited 2×
“This revolution stems from new knowledge that the lung is not sterile (10) and, in fact, harbors an abundance of diverse interacting microbiota.”
BackgroundSelf-citationBassis, C. M., Erb-Downward, J. R., Dickson, R. P., Freeman, C. M., Schmidt, T. M., Young, V. B., Beck, J. M., Curtis, J. L., & Huffnagle, G. B. (2015) · mBio · doi:10.1128/mbio.00037-15 · Cited by 839 · cited 1×
“Importantly, the mouth and nose microbiota are markedly different and studies have not identified any detectable influence on the reported microbiota based on scope insertion site (22, 23).”
BackgroundSelf-citationComparison of the Respiratory Microbiome in Healthy Nonsmokers and Smokers
Morris, A., Beck, J. M., Schloss, P. D., Campbell, T. B., Crothers, K., Curtis, J. L., Flores, S. C., Fontenot, A. P., Ghedin, E., Huang, L., et al. (2013) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201210-1913oc · Cited by 822
Low diversity of the gut microbiota in infants with atopic eczema
Abrahamsson, T. R., Jakobsson, H. E., Andersson, A. F., Björkstén, B., Engstrand, L., & Jenmalm, M. C. (2012) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2011.10.025 · Cited by 815
Pharyngeal aspiration in normal adults and patients with depressed consciousness
Huxley, E. J., Viroslav, J., Gray, W. R., & Pierce, A. K. (1978) · The American Journal of Medicine · doi:10.1016/0002-9343(78)90574-0 · Cited by 739 · cited 2×
“local defense is blunted or overwhelmed (17, 18).”
Background`Ome Sweet `Omics--A Genealogical Treasury of Words
Lederberg, J., & McCray, A. T. (2001) · The Scientist (Philadelphia, Pa. Online)/The Scientist · Cited by 736
Bleomycin and IL-1β–mediated pulmonary fibrosis is IL-17A dependent
Wilson, M. S., Madala, S. K., Ramalingam, T. R., Gochuico, B. R., Rosas, I. O., Cheever, A. W., & Wynn, T. A. (2010) · Journal of Experimental Medicine · doi:10.1084/jem.20092121 · Cited by 730 · cited 1×
“Several studies have implicated IL-17 in hepatic fibrosis, and certain experimental models of pulmonary fibrosis are IL-17A–dependent (120, 122, 123).”
BackgroundAirway microbiota and bronchial hyperresponsiveness in patients with suboptimally controlled asthma
Huang, Y. J., Nelson, C. E., Brodie, E. L., DeSantis, T. Z., Baek, M. S., Liu, J., Woyke, T., Allgaier, M., Bristow, J., Wiener-Kronish, J. P., et al. (2011) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2010.10.048 · Cited by 696
High prevalence of abnormal acid gastro-oesophageal reflux in idiopathic pulmonary fibrosis
Raghu, G., Freudenberger, T. D., Yang, S., Curtis, J. R., Spada, C., Hayes, J., Sillery, J. K., Pope, C. E., & Pellegrini, C. A. (2006) · European Respiratory Journal · doi:10.1183/09031936.06.00037005 · Cited by 643
Antarctic Sea Ice--a Habitat for Extremophiles
Thomas, D. N., & Dieckmann, G. S. (2002) · Science · doi:10.1126/science.1063391 · Cited by 629
Pharyngeal aspiration in normal adults and patients with depressed consciousness
(1978) · The American Journal of Medicine · doi:10.1016/0002-9343(78)90607-1 · Cited by 604
Decade-long bacterial community dynamics in cystic fibrosis airways
Zhao, J., Schloss, P. D., Kalikin, L. M., Carmody, L. A., Foster, B. K., Petrosino, J. F., Cavalcoli, J. D., VanDevanter, D. R., Murray, S., Li, J. Z., et al. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1120577109 · Cited by 599
Lung microbiota promotes tolerance to allergens in neonates via PD-L1
Gollwitzer, E. S., Saglani, S., Trompette, A., Yadava, K., Sherburn, R., McCoy, K. D., Nicod, L. P., Lloyd, C. M., & Marsland, B. J. (2014) · Nature Medicine · doi:10.1038/nm.3568 · Cited by 596 · cited 2×
“Murine studies have demonstrated that bacterial load in the lungs increases during the first 2 wk of life, and the phyla of organisms found in the lung shifted from Gammaproteobacteria and Firmicutes toward Bacteriodetes (35).”
BackgroundBiesbroek, G., Tsivtsivadze, E., Sanders, E. A. M., Montijn, R., Veenhoven, R. H., Keijser, B. J. F., & Bogaert, D. (2014) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201407-1240oc · Cited by 572 · cited 1×
“However, it is likely from studies of the upper respiratory tract and intestinal microbiota that these bacterial communities are dynamic (37, 38).”
BackgroundDickson, R. P., Erb-Downward, J. R., Freeman, C. M., McCloskey, L., Beck, J. M., Huffnagle, G. B., & Curtis, J. L. (2015) · Annals of the American Thoracic Society · doi:10.1513/annalsats.201501-029oc · Cited by 567 · cited 1×
“Several studies have established that this is not the case (19, 24).”
BackgroundSelf-citationThe role of bacteria in the pathogenesis and progression of idiopathic pulmonary fibrosis
Molyneaux, P. L., Cox, M. J., Willis-Owen, S. A. G., Mallia, P., Russell, K. E., Russell, A.-M., Murphy, E., Johnston, S. L., Schwartz, D. A., Wells, A. U., et al. (2014) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201403-0541oc · Cited by 567 · cited 1×
“(76) described an increased bacterial burden in the bronchoalveolar lavage fluid of IPF patients compared with controls using culture-independent techniques.”
ResultMonsó, E., Ruiz, J., Rosell, A., Manterola, J., Fiz, J., Morera, J., & Ausina, V (1995) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.152.4.7551388 · Cited by 562
The Lung Tissue Microbiome in Chronic Obstructive Pulmonary Disease
Sze, M. A., Dimitriu, P. A., Hayashi, S., Elliott, W. M., McDonough, J. E., Gosselink, J. V., Cooper, J., Sin, D. D., Mohn, W. W., & Hogg, J. C. (2012) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201111-2075oc · Cited by 552
Rohde, G. (2003) · Thorax · doi:10.1136/thorax.58.1.37 · Cited by 524
Management of Pulmonary Disease in Patients with Cystic Fibrosis
Ramsey, B. W. (1996) · New England Journal of Medicine · doi:10.1056/nejm199607183350307 · Cited by 502
Wang, J., Li, F., Wei, H., Lian, Z.-X., Sun, R., & Tian, Z. (2014) · Journal of Experimental Medicine · doi:10.1084/jem.20140625 · Cited by 490
Segal, L. N., Alekseyenko, A. V., Clemente, J. C., Kulkarni, R., Wu, B., Chen, H., Berger, K. I., Goldring, R. M., Rom, W. N., Blaser, M. J., et al. (2013) · Microbiome · doi:10.1186/2049-2618-1-19 · Cited by 482 · cited 6×
“Sequencing-based studies of tissue from COPD patients have demonstrated an increase in the Firmicutes community in severe disease (GOLD stage 4) attributable to an increase in the Lactobacillus genus (41).”
BackgroundInfluentialFloto, R. A., Olivier, K. N., Saiman, L., Daley, C. L., Herrmann, J.-L., Nick, J. A., Noone, P. G., Bilton, D., Corris, P., Gibson, R. L., et al. (2016) · Thorax · doi:10.1136/thoraxjnl-2015-207360 · Cited by 466
Floto, R. A., Olivier, K. N., Saiman, L., Daley, C. L., Herrmann, J.-L., Nick, J. A., Noone, P. G., Bilton, D., Corris, P., Gibson, R. L., et al. (2016) · Thorax · doi:10.1136/thoraxjnl-2015-207983 · Cited by 462
Airway Microbiota and Pathogen Abundance in Age-Stratified Cystic Fibrosis Patients
Cox, M. J., Allgaier, M., Taylor, B., Baek, M. S., Huang, Y. J., Daly, R. A., Karaoz, U., Andersen, G. L., Brown, R., Fujimura, K. E., et al. (2010) · PLoS ONE · doi:10.1371/journal.pone.0011044 · Cited by 451
Quantitative Aspiration During Sleep in Normal Subjects
Gleeson, K., Maxwell, S. L., & Eggli, D. F. (1997) · Chest · doi:10.1378/chest.111.5.1266 · Cited by 448
Kudo, M., Melton, A. C., Chen, C., Engler, M. B., Huang, K. E., Ren, X., Wang, Y., Bernstein, X., Li, J. T., Atabai, K., et al. (2012) · Nature Medicine · doi:10.1038/nm.2684 · Cited by 446
The lung microbiome in moderate and severe chronic obstructive pulmonary disease
Pragman, A. A., Kim, H. B., Reilly, C. S., Wendt, C., & Isaacson, R. E. (2012) · PLoS ONE · doi:10.1371/journal.pone.0047305 · Cited by 437
Khor, C. C., Chapman, S. J., Vannberg, F. O., Dunne, A., Murphy, C., Ling, E. Y., Frodsham, A. J., Walley, A. J., Kyrieleis, O., Khan, A., et al. (2007) · Nature Genetics · doi:10.1038/ng1976 · Cited by 432
Antibiotics for exacerbations of chronic obstructive pulmonary disease
Vollenweider, D. J., Jarrett, H., Steurer-Stey, C. A., Garcia-Aymerich, J., & Puhan, M. A. (2012) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd010257 · Cited by 425
The Human Nasal Microbiota and Staphylococcus aureus Carriage
Frank, D. N., Feazel, L. M., Bessesen, M. T., Price, C. S., Janoff, E. N., & Pace, N. R. (2010) · PLoS ONE · doi:10.1371/journal.pone.0010598 · Cited by 422
Mallia, P., Message, S. D., Gielen, V., Contoli, M., Gray, K., Kebadze, T., Aniscenko, J., Laza-Stanca, V., Edwards, M. R., Slater, L., et al. (2011) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201006-0833oc · Cited by 415
Han, M. K., Zhou, Y., Murray, S., Tayob, N., Noth, I., Lama, V. N., Moore, B. B., White, E. S., Flaherty, K. R., Huffnagle, G. B., et al. (2014) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(14)70069-4 · Cited by 411
Self-citationChronic Mycobacterium abscessus infection and lung function decline in cystic fibrosis
Esther, C. R., Esserman, D. A., Gilligan, P., Kerr, A., & Noone, P. G. (2010) · Journal of Cystic Fibrosis · doi:10.1016/j.jcf.2009.12.001 · Cited by 410
Molyneaux, P. L., Mallia, P., Cox, M. J., Footitt, J., Willis-Owen, S. A. G., Homola, D., Trujillo-Torralbo, M.-B., Elkin, S., Kon, O. M., Cookson, W. O. C., et al. (2013) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201302-0341oc · Cited by 390 · cited 2×
“In COPD, exacerbations can occur due to viral infections (60, 111), and resulting pathogenesis could be the result of dysbiosis leading to altered airway microbiota and disproportionate inflammation.”
BackgroundAsthma-associated differences in microbial composition of induced sputum
Marri, P. R., Stern, D. A., Wright, A. L., Billheimer, D., & Martinez, F. D. (2013) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2012.11.013 · Cited by 380
Genetic variation in Toll-like receptors and disease susceptibility
Netea, M. G., Wijmenga, C., & O'Neill, L. A. J. (2012) · Nature Immunology · doi:10.1038/ni.2284 · Cited by 376
Charlson, E. S., Diamond, J. M., Bittinger, K., Fitzgerald, A. S., Yadav, A., Haas, A. R., Bushman, F. D., & Collman, R. G. (2012) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201204-0693oc · Cited by 348
Tan, Z., Qian, X., Jiang, R., Liu, Q., Wang, Y., Chen, C., Wang, X., Ryffel, B., & Sun, B. (2013) · The Journal of Immunology · doi:10.4049/jimmunol.1203013 · Cited by 330
Role of Antibiotics and Fungal Microbiota in Driving Pulmonary Allergic Responses
Noverr, M. C., Noggle, R. M., Toews, G. B., & Huffnagle, G. B. (2004) · Infection and Immunity · doi:10.1128/iai.72.9.4996-5003.2004 · Cited by 330
Sassone-Corsi, M., & Raffatellu, M. (2015) · The Journal of Immunology · doi:10.4049/jimmunol.1403169 · Cited by 328
Airway microbiome dynamics in exacerbations of chronic obstructive pulmonary disease
Huang, Y. J., Sethi, S., Murphy, T., Nariya, S., Boushey, H. A., & Lynch, S. V. (2014) · Journal of Clinical Microbiology · doi:10.1128/jcm.00035-14 · Cited by 323 · cited 1×
“(53) reported an alteration in community content toward the Proteobacteria phylum during COPD exacerbations, including nontypical COPD pathogens.”
BackgroundAitken, M. L., Limaye, A., Pottinger, P., Whimbey, E., Goss, C. H., Tonelli, M. R., Cangelosi, G. A., Dirac, M. A., Olivier, K. N., Brown-Elliott, B. A., et al. (2012) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.185.2.231 · Cited by 310
Smith, A. L., Fiel, S. B., Mayer-Hamblett, N., Ramsey, B., & Burns, J. L. (2003) · Chest · doi:10.1378/chest.123.5.1495 · Cited by 307
Sarcoidosis is a Th1/Th17 multisystem disorder
Facco, M., Cabrelle, A., Teramo, A., Olivieri, V., Gnoato, M., Teolato, S., Ave, E., Gattazzo, C., Fadini, G. P., Calabrese, F., et al. (2011) · Thorax · doi:10.1136/thx.2010.140319 · Cited by 295
Perinatal antibiotic treatment affects murine microbiota, immune responses and allergic asthma
Russell, S. L., Gold, M. J., Willing, B. P., Thorson, L., McNagny, K. M., & Finlay, B. B. (2013) · Gut Microbes · doi:10.4161/gmic.23567 · Cited by 279
Usual interstitial pneumonia: histologic correlation with high-resolution CT.
Nishimura, K., Kitaichi, M., Izumi, T., Nagai, S., Kanaoka, M., & Itoh, H. (1992) · Radiology · doi:10.1148/radiology.182.2.1732946 · Cited by 267
The response of the lymphatic tissue to the microbial flora. Studies on germfree mice.
Bauer, H., Horowitz, R. E., Levenson, S. Μ., & Pópper, H. (1963) · PubMed Central · Cited by 257
Pulmonary exacerbations in cystic fibrosis
Rabin, H. R., Butler, S. M., Wohl, M. E. B., Geller, D. E., Colin, A. A., Schidlow, D. V., Johnson, C. A., Konstan, M. W., & Regelmann, W. E. (2004) · Pediatric Pulmonology · doi:10.1002/ppul.20023 · Cited by 245
Fagundes, C. T., Amaral, F. A., Vieira, A. T., Soares, A. C., Pinho, V., Nicoli, J. R., Vieira, L. Q., Teixeira, M. M., & Souza, D. G. (2012) · The Journal of Immunology · doi:10.4049/jimmunol.1101682 · Cited by 244
Changes in cystic fibrosis airway microbiota at pulmonary exacerbation
Carmody, L. A., Zhao, J., Schloss, P. D., Petrosino, J. F., Murray, S., Young, V. B., Li, J. Z., & LiPuma, J. J. (2013) · Annals of the American Thoracic Society · doi:10.1513/annalsats.201211-107oc · Cited by 239
Microbiota-mediated inflammation and antimicrobial defense in the intestine
Caballero, S., & Pamer, E. G. (2015) · Annual Review of Immunology · doi:10.1146/annurev-immunol-032713-120238 · Cited by 238
Bruzzese, E., Callegari, M. L., Raia, V., Viscovo, S., Scotto, R., Ferrari, S., Morelli, L., Buccigrossi, V., Lo Vecchio, A., Ruberto, E., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0087796 · Cited by 217
Sanguinetti, M., Ardito, F., Fiscarelli, E., La Sorda, M., D'Argenio, P., Ricciotti, G., & Fadda, G. (2001) · Journal of Clinical Microbiology · doi:10.1128/jcm.39.2.816-819.2001 · Cited by 210
Intestinal Microbiota of Mice Influences Resistance to Staphylococcus aureus Pneumonia
Gauguet, S., D'Ortona, S., Ahnger-Pier, K., Duan, B., Surana, N. K., Lu, R., Cywes-Bentley, C., Gadjeva, M., Shan, Q., Priebe, G. P., et al. (2015) · Infection and Immunity · doi:10.1128/iai.00037-15 · Cited by 208
Dickson, R. P., Erb-Downward, J. R., Freeman, C. M., Walker, N., Scales, B. S., Beck, J. M., Martinez, F. J., Curtis, J. L., Lama, V. N., & Huffnagle, G. B. (2014) · PLoS ONE · doi:10.1371/journal.pone.0097214 · Cited by 206
Self-citationAcute exacerbation of idiopathic pulmonary fibrosis: shifting the paradigm
Ryerson, C. J., Cottin, V., Brown, K. K., & Collard, H. R. (2015) · European Respiratory Journal · doi:10.1183/13993003.00419-2015 · Cited by 205
Deep Sequencing Identifies Ethnicity-Specific Bacterial Signatures in the Oral Microbiome
Mason, M. R., Nagaraja, H. N., Camerlengo, T., Joshi, V., & Kumar, P. S. (2013) · PLoS ONE · doi:10.1371/journal.pone.0077287 · Cited by 204
The Th17 Pathway in Cystic Fibrosis Lung Disease
Tan, H.-L., Regamey, N., Brown, S., Bush, A., Lloyd, C. M., & Davies, J. C. (2011) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201102-0236oc · Cited by 201
Airway Bacterial Concentrations and Exacerbations of Chronic Obstructive Pulmonary Disease
Sethi, S., Sethi, R., Eschberger, K., Lobbins, P., Cai, X., Grant, B. J. B., & Murphy, T. F. (2007) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200703-417oc · Cited by 200
Clarke, T. B. (2014) · Infection and Immunity · doi:10.1128/iai.02212-14 · Cited by 189 · cited 2×
“Support for such a concept comes from recent work showing that bacterial activation of Nod-like receptors in the gut leads to enhanced production of reactive oxygen species within alveolar macrophages, the sentinel innate immune cell within the lung (101), implying that conditions associated with loss of gut bacterial…”
BackgroundThe Th17 pathway in Cystic Fibrosis lung disease
Tan, H. (2011) · doi:10.25560/9635 · Cited by 188
The Toll-like Receptor 3 L412F Polymorphism and Disease Progression in Idiopathic Pulmonary Fibrosis
O’Dwyer, D. N., Armstrong, M. E., Trujillo, G., Cooke, G., Keane, M. P., Fallon, P. G., Simpson, A. J., Millar, A. B., McGrath, E. E., Whyte, M. K., et al. (2013) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201304-0760oc · Cited by 186
Self-citationThe role of viral infections in exacerbations of chronic obstructive pulmonary disease and asthma
Hewitt, R., Farne, H., Ritchie, A., Luke, E., Johnston, S. L., & Mallia, P. (2016) · Therapeutic Advances in Respiratory Disease · doi:10.1177/1753465815618113 · Cited by 186
Microbiota Promotes Chronic Pulmonary Inflammation by Enhancing IL-17A and Autoantibodies
Yadava, K., Pattaroni, C., Sichelstiel, A. K., Trompette, A., Gollwitzer, E. S., Salami, O., von Garnier, C., Nicod, L. P., & Marsland, B. J. (2016) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201504-0779oc · Cited by 184 · cited 1×
“(121) reported the impact of experimental change on the lung microbiota in an emphysema animal model.”
BackgroundCOMPARING BACTERIAL COMMUNITIES INFERRED FROM 16S rRNA GENE SEQUENCING AND SHOTGUN METAGENOMICS
Shah, N., Tang, H., Doak, T. G., & Ye, Y. (2010) · Biocomputing 2011 · doi:10.1142/9789814335058_0018 · Cited by 182
The Role of the IL23/IL17 Axis in Bronchiolitis Obliterans Syndrome After Lung Transplantation
Vanaudenaerde, B. M., De Vleeschauwer, S. I., Vos, R., Meyts, I., Bullens, D. M., Reynders, V., Wuyts, W. A., Van Raemdonck, D. E., Dupont, L. J., & Verleden, G. M. (2008) · American Journal of Transplantation · doi:10.1111/j.1600-6143.2008.02321.x · Cited by 171
Regional Differences in the Lung
West, J. B. (1978) · Chest · doi:10.1016/s0012-3692(15)37392-x · Cited by 163
Tomosada, Y., Chiba, E., Zelaya, H., Takahashi, T., Tsukida, K., Kitazawa, H., Alvarez, S., & Villena, J. (2013) · BMC Immunology · doi:10.1186/1471-2172-14-40 · Cited by 162
TLR9 Differentiates Rapidly from Slowly Progressing Forms of Idiopathic Pulmonary Fibrosis
Trujillo, G., Meneghin, A., Flaherty, K. R., Sholl, L. M., Myers, J. L., Kazerooni, E. A., Gross, B. H., Oak, S. R., Coelho, A. L., Evanoff, H., et al. (2010) · Science Translational Medicine · doi:10.1126/scitranslmed.3001510 · Cited by 160
Heterogeneity of Vaginal Microbial Communities within Individuals
Kim, T. K., Thomas, S. M., Ho, M., Sharma, S., Reich, C. I., Frank, J. A., Yeater, K. M., Biggs, D. R., Nakamura, N., Stumpf, R., et al. (2009) · Journal of Clinical Microbiology · doi:10.1128/jcm.00854-08 · Cited by 158
Bronchial microbiome of severe COPD patients colonised by Pseudomonas aeruginosa
Millares, L., Ferrari, R., Gallego, M., Garcia-Nuñez, M., Pérez-Brocal, V., Espasa, M., Pomares, X., Monton, C., Moya, A., & Monsó, E. (2014) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-013-2044-0 · Cited by 136 · cited 1×
“(52) analyzed sputum from COPD patients during exacerbations with paired sampling from periods of clinical stability and found increases in the relative abundance of bacteria associated with exacerbations, namely Haemophilus, Pseudomonas, and Moraxella.”
BackgroundPrice, K. E., Hampton, T. H., Gifford, A. H., Dolben, E. L., Hogan, D. A., Morrison, H. G., Sogin, M. L., & O’Toole, G. A. (2013) · Microbiome · doi:10.1186/2049-2618-1-27 · Cited by 135
Does bacterial density in cystic fibrosis sputum increase prior to pulmonary exacerbation?
Stressmann, F. A., Rogers, G. B., Marsh, P., Lilley, A. K., Daniels, T. W. V., Carroll, M. P., Hoffman, L. R., Jones, G., Allen, C. E., Patel, N., et al. (2011) · Journal of Cystic Fibrosis · doi:10.1016/j.jcf.2011.05.002 · Cited by 130
Hurley, M. N., Ariff, A. H. A., Bertenshaw, C., Bhatt, J., & Smyth, A. R. (2012) · Journal of Cystic Fibrosis · doi:10.1016/j.jcf.2012.02.006 · Cited by 122
Collawn, J. F., & Matalon, S. (2014) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00326.2014 · Cited by 112
Mortaz, E., Adcock, I. M., Ricciardolo, F. L. M., Varahram, M., Jamaati, H., Velayati, A. A., Folkerts, G., & Garssen, J. (2015) · PLOS ONE · doi:10.1371/journal.pone.0136455 · Cited by 105
Yamamoto, H., Hiraishi, A., Kato, K., Chiura, H. X., Maki, Y., & Shimizu, A. (1998) · Applied and Environmental Microbiology · doi:10.1128/aem.64.5.1680-1687.1998 · Cited by 104
Pulmonary exacerbations in cystic fibrosis
Stenbit, A. E., & Flume, P. A. (2011) · Current Opinion in Pulmonary Medicine · doi:10.1097/mcp.0b013e32834b8c04 · Cited by 99
Streptococcus pneumoniae triggers progression of pulmonary fibrosis through pneumolysin
Knippenberg, S., Ueberberg, B., Maus, R., Bohling, J., Ding, N., Tort Tarres, M., Hoymann, H.-G., Jonigk, D., Izykowski, N., Paton, J. C., et al. (2015) · Thorax · doi:10.1136/thoraxjnl-2014-206420 · Cited by 99
Gut Microbiota Regulates K/BxN Autoimmune Arthritis through Follicular Helper T but Not Th17 Cells
Block, K. E., Zheng, Z., Dent, A. L., Kee, B. L., & Huang, H. (2016) · The Journal of Immunology · doi:10.4049/jimmunol.1501904 · Cited by 99
Respiratory microbiota: addressing clinical questions, informing clinical practice
Rogers, G. B., Shaw, D., Marsh, R. L., Carroll, M. P., Serisier, D. J., & Bruce, K. D. (2015) · Thorax · doi:10.1136/thoraxjnl-2014-205826 · Cited by 96 · cited 1×
“Further steps that may alter the accuracy and reliability of acquired data include the generation of appropriate PCR primers, data normalization, the choice of reference database, and divergent measures of diversity (25).”
BackgroundSamara, K. D., Antoniou, K. M., Karagiannis, K., Μαργαριτόπουλος, Γ., Lasithiotaki, I., Koutala, E., & Siafakas, N. M. (2012) · International Journal of Oncology · doi:10.3892/ijo.2012.1374 · Cited by 92
IL-17 in lung disease: friend or foe?
Tan, H., & Rosenthal, M. (2013) · Thorax · doi:10.1136/thoraxjnl-2013-203307 · Cited by 91
The Nasal and Sinus Microbiome in Health and Disease
Wilson, M. T., & Hamilos, D. L. (2014) · Current Allergy and Asthma Reports · doi:10.1007/s11882-014-0485-x · Cited by 86
Gold, R., Carpenter, S., Heurter, H., Corey, M. L., & Levison, H. (1987) · The Journal of Pediatrics · doi:10.1016/s0022-3476(87)80217-2 · Cited by 78
Inagaki, H., Suzuki, T., Nomoto, K., & Yoshikai, Y. (1996) · Infection and Immunity · doi:10.1128/iai.64.8.3280-3287.1996 · Cited by 75
Prevalence of Gastroesophageal Reflux in Cystic Fibrosis and Implications for Lung Disease
Robinson, N. B., & DiMango, E. (2014) · Annals of the American Thoracic Society · doi:10.1513/annalsats.201401-044fr · Cited by 71
ELMOD2 , a candidate gene for idiopathic pulmonary fibrosis, regulates antiviral responses
Pulkkinen, V., Bruce, S., Rintahaka, J., Hodgson, U., Laitinen, T., Alenius, H., Kinnula, V. L., Myllarniemi, M., Matikainen, S., & Kere, J. (2010) · The FASEB Journal · doi:10.1096/fj.09-138545 · Cited by 67
Jaspers, I. (2014) · Annals of the American Thoracic Society · doi:10.1513/annalsats.201306-154mg · Cited by 66
Chewning, J. H., & Weaver, C. T. (2014) · The Journal of Immunology · doi:10.4049/jimmunol.1401835 · Cited by 59
Indirect assessment of mucosal surface temperatures in the airways: theory and tests
Ingenito, E. P., Solway, J., McFadden, E. R., Pichurko, B., Bowman, H. F., Michaels, D., & Drazen, J. M. (1987) · Journal of Applied Physiology · doi:10.1152/jappl.1987.63.5.2075 · Cited by 59
Zhu, B., Xiao, D., Zhang, H., Zhang, Y., Gao, Y., Xu, L., Lv, J., Wang, Y., Zhang, J., & Shao, Z. (2013) · PLoS ONE · doi:10.1371/journal.pone.0056139 · Cited by 54
Varney, V., Parnell, H., Salisbury, D., Ratnatheepan, S., & Tayar, R. (2007) · Pulmonary Pharmacology & Therapeutics · doi:10.1016/j.pupt.2007.02.001 · Cited by 53
Association of toll-like receptor 3 gene polymorphism with subacute sclerosing panencephalitis
Ishizaki, Y., Takemoto, M., Kira, R., Kusuhara, K., Torisu, H., Sakai, Y., Sanefuji, M., Yukaya, N., & Hara, T. (2008) · Journal of NeuroVirology · doi:10.1080/13550280802298120 · Cited by 52
Manuzak, J. A., Hensley-McBain, T., Zevin, A. S., Miller, C., Cubas, R., Agricola, B., Gile, J., Richert-Spuhler, L., Patilea, G., Estes, J. D., et al. (2016) · The Journal of Immunology · doi:10.4049/jimmunol.1502470 · Cited by 52
Detection of Herpes Simplex Virus Type-1 in Patients with Fibrotic Lung Diseases
Lasithiotaki, I., Antoniou, K. M., Vlahava, V.-M., Karagiannis, K., Spandidos, D. A., Siafakas, N. M., & Sourvinos, G. (2011) · PLoS ONE · doi:10.1371/journal.pone.0027800 · Cited by 51
Host–microbe interactions in distal airways: relevance to chronic airway diseases
Martin, C., Burgel, P., Lepage, P., Andréjak, C., Jacques de, B. L. I. C., BOURDIN, A. A., Brouard, J., Chanez, P., Dalphin, J., Deslée, G., et al. (2015) · European Respiratory Review · doi:10.1183/09059180.00011614 · Cited by 51
Ray, S., De Salvo, C., & Pizarro, T. T. (2014) · Current Opinion in Gastroenterology · doi:10.1097/mog.0000000000000119 · Cited by 49
New Insights into the Mechanisms of Innate Immune Receptor Signalling in Fibrosis
Lafyatis, R., & Farina, G. A. (2012) · The Open Rheumatology Journal · doi:10.2174/1874312901206010072 · Cited by 49
REGIONAL DIFFERENCES IN THE LUNG
Ashbaugh, D. G. (1978) · CHEST Journal · doi:10.1016/s0012-3692(16)38653-6 · Cited by 42
Folcik, V. A., Garofalo, M., Coleman, J., Donegan, J. J., Rabbani, E., Suster, S. M., Nuovo, A., MAGRO, C. M. J., Leva, G. D., & Nuovo, G. J. (2013) · Modern Pathology · doi:10.1038/modpathol.2013.198 · Cited by 41
Zhou, X., Loomis-King, H. A., Gurczynski, S. J., Wilke, C. A., Konopka, K. E., Ptaschinski, C., Coomes, S. M., Iwakura, Y., van Dyk, L. F., Lukacs, N. W., et al. (2015) · Mucosal Immunology · doi:10.1038/mi.2015.85 · Cited by 41
Self-citationAirway impedance entropy and exacerbations in severe asthma
Gonem, S., Umar, I., Burke, D. L., Desai, D., Corkill, S., Owers-Bradley, J. R., Brightling, C. E., & Siddiqui, S. (2012) · European Respiratory Journal · doi:10.1183/09031936.00228611 · Cited by 37
Margaritopoulos, G., Antoniou, K. M., Karagiannis, K., Samara, K. D., Lasithiotaki, I., Vassalou, E., Lymbouridou, R., Koutala, H., & Siafakas, N. M. (2010) · Fibrogenesis & Tissue Repair · doi:10.1186/1755-1536-3-20 · Cited by 35
A New Method of Enumerating Bacteria in Air
Winslow, C. ‐. A. (1908) · Science · doi:10.1126/science.28.705.28 · Cited by 29
Exacerbation phenotyping in chronic obstructive pulmonary disease
MacDonald, M., Korman, T. M., King, P. T., Hamza, K., & Bardin, P. G. (2013) · Respirology · doi:10.1111/resp.12197 · Cited by 26
Papanikolaou, I. C., Boki, K. A., Giamarellos‐Bourboulis, E. J., Kotsaki, A., Kagouridis, K., Karagiannidis, N., & Polychronopoulos, V. (2014) · Immunology Letters · doi:10.1016/j.imlet.2014.12.004 · Cited by 23
Lemaire, M. M., Dumoutier, L., Warnier, G., Uyttenhove, C., Snick, J. V., de Heusch, M., Stevens, M., & Renauld, J. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.1101720 · Cited by 22
Cited by
Aspergillus fumigatus and Aspergillosis in 2019
Latgé, J.-P., & Chamilos, G. (2019) · Clinical Microbiology Reviews · doi:10.1128/cmr.00140-18 · Cited by 1,400
The microbiome and human cancer
Sepich-Poore, G. D., Zitvogel, L., Straussman, R., Hasty, J., Wargo, J. A., & Knight, R. (2021) · Science · doi:10.1126/science.abc4552 · Cited by 1,332
“For instance, the lungs’ surface approximates 1 m(2) per kg of body weight and is not sterile (108).”
BackgroundCystic Fibrosis and Pseudomonas aeruginosa: the Host-Microbe Interface
Malhotra, S., Hayes, D., & Wozniak, D. J. (2019) · Clinical Microbiology Reviews · doi:10.1128/cmr.00138-18 · Cited by 515
Shen, Z., Xiao, Y., Kang, L., Ma, W., Shi, L., Zhang, L., Zhou, Z., Yang, J., Zhong, J., Yang, D., et al. (2020) · Clinical Infectious Diseases · doi:10.1093/cid/ciaa203 · Cited by 513
“ated with disease susceptibility and severity [7].”
Targeting the gut and tumor microbiota in cancer
Park, E. M., Chelvanambi, M., Bhutiani, N., Kroemer, G., Zitvogel, L., & Wargo, J. A. (2022) · Nature Medicine · doi:10.1038/s41591-022-01779-2 · Cited by 496
Metadata
- Authors
- O’Dwyer, D. N., Dickson, R. P., & Moore, B. B.
- Affiliations
- Michigan Medicine (US)
- University of Michigan (US)
- Corresponding author
- Moore, Bethany B
- Venue
- The Journal of Immunology
- Publisher
- Oxford University Press (OUP)
- Published
- 2016-06
- Volume
- 196
- Issue
- 12
- Pages
- 4839-4847
- ISSN
- 0022-1767 (ISSN-L)
- 1550-6606
- PMC
- PMC4894335
- OpenAlex
- W2413745624
- Cited by
- 362
- References
- 134
- Citations by year
- 2026: 17 · 2025: 25 · 2024: 31 · 2023: 39 · 2022: 50 · 2021: 55 · 2020: 65 · 2019: 34 · 2018: 26 · 2017: 15 · 2016: 4
- FWCI
- 4.56
- Type
- journal article
- Language
- en
- Open access
- green
- europepmc.org
- Locations
- The Journal of Immunology (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Institutes of Health (UL1TR000433)
- National Heart, Lung, and Blood Institute (R01HL115618, L30 HL120241, R01HL119682, K23HL130641, R01HL127805, T32HL007749)
- National Institute of Allergy and Infectious Diseases (R01AI117229)
- National Center for Advancing Translational Sciences
- Topics
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Chronic Obstructive Pulmonary Disease (COPD) Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Asthma and respiratory diseases
- Keywords
- lung microbiome, chronic lung disease, dysbiosis, lung immunity, disease exacerbation, host-microbe interactions, bacterial diversity, pathogenesis
- MeSH terms
- Bacteria, Chronic Disease, Homeostasis, Humans, Lung, Lung Diseases, Disease Progression, Host-Pathogen Interactions, Microbiota, Dysbiosis
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.